Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Sihuan Pharmaceutical Holdings Group ( (HK:0460) ) is now available.
Sihuan Pharmaceutical Holdings Group announced a share repurchase plan, buying back 13,096,000 shares at an average price of HK$1.4945, reflecting their confidence in the company’s future. The company is experiencing significant growth in its medical aesthetics and innovative pharmaceuticals sectors, with a notable increase in revenue and the launch of new products, which are expected to drive future revenue and profit growth.
The most recent analyst rating on (HK:0460) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Sihuan Pharmaceutical Holdings Group stock, see the HK:0460 Stock Forecast page.
More about Sihuan Pharmaceutical Holdings Group
Sihuan Pharmaceutical Holdings Group, founded in 2001 and listed on the Main Board of the Stock Exchange in 2010, is an international company focused on medical aesthetics and biopharmaceuticals. The company is driven by innovation, boasting a strong research and development platform, a comprehensive product pipeline, and a robust sales system. Sihuan Pharmaceutical aims to become a leading entity in China through its dual focus on medical aesthetics and biopharmaceutical businesses.
Average Trading Volume: 113,181,107
Technical Sentiment Signal: Buy
Current Market Cap: HK$13.62B
For an in-depth examination of 0460 stock, go to TipRanks’ Overview page.